£88m Series B For Syncona-backed Freeline To Advance Liver Gene Therapy Focus

 
• By Sten Stovall
  
Dollar boat
Freeline's Series B Financing Refloats Gene Therapy Specialist • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business